Fatigue as Mediator Factor in PTSD-Symptoms after Allogeneic Hematopoietic Stem Cell Transplantation.
Giulia Di FrancescoFilippo CieriRoberto EspositoPierpaola SciarraValeria BallariniMauro Di IanniStella SantaronePublished in: Journal of clinical medicine (2023)
Our findings indicate that QoL is a concurrent causative factor to the development of PTSD symptomatology through the mediating role of fatigue. Innovative interventions before transplantation to prevent PTSD symptoms should be investigated to improve survival and QoL in patients.
Keyphrases
- allogeneic hematopoietic stem cell transplantation
- sleep quality
- posttraumatic stress disorder
- end stage renal disease
- social support
- newly diagnosed
- chronic kidney disease
- ejection fraction
- acute myeloid leukemia
- prognostic factors
- acute lymphoblastic leukemia
- physical activity
- depressive symptoms
- stem cells
- squamous cell carcinoma
- mesenchymal stem cells
- locally advanced
- high resolution
- patient reported
- radiation therapy